Advertisement
Home »

Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study.

Aug 21, 2023

ABOUT THE EXPERTS

  • Thu Thi Pham

    Molecular Epidemiology Research Group, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.

    Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.

    Katharina Nimptsch

    Molecular Epidemiology Research Group, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.

    Nikos Papadimitriou

    Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, 150 Cours Albert Thomas, 69372, Lyon, Cedex 08, France.

    Krasimira Aleksandrova

    Department of Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, 28359, Bremen, Germany.

    Faculty of Human and Health Sciences, University of Bremen, 28359, Bremen, Germany.

    Mazda Jenab

    Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, 150 Cours Albert Thomas, 69372, Lyon, Cedex 08, France.

    Marc J Gunter

    Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, 150 Cours Albert Thomas, 69372, Lyon, Cedex 08, France.

    Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

    Loic Le Marchand

    Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.

    Li Li

    Department of Family Medicine and UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USA.

    Brigid M Lynch

    Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.

    Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

    Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.

    Sergi Castellví-Bel

    Department of Gastroenterology, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

    Amanda I Phipps

    Fred Hutchinson Cancer Center, Seattle, WA, USA.

    Stephanie L Schmit

    Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

    Population and Cancer Prevention Program, Case Comprehensive Cancer Center, Cleveland, OH, USA.

    Hermann Brenner

    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

    Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

    Shuji Ogino

    Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.

    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

    Broad Institute of MIT and Harvard, Cambridge, MA, USA.

    Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, MA, USA.

    Edward Giovannucci

    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

    Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

    Tobias Pischon

    Molecular Epidemiology Research Group, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany. tobias.pischon@mdc-berlin.de.

    Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany. tobias.pischon@mdc-berlin.de.

    Biobank Technology Platform, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany. tobias.pischon@mdc-berlin.de.

    Core Facility Biobank, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13125, Berlin, Germany. tobias.pischon@mdc-berlin.de.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement